MedPath

Mediline (Hong Kong) Company Limited

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

50

PPB:50

Drug Approvals

MODSENAL CAPSULES 50MG

Approval Date
May 12, 2025
PPB

VOFLOX TABLETS 500MG

Approval Date
Jun 18, 2024
PPB

VOFLOX TABLETS 250MG

Approval Date
Jun 18, 2024
PPB

TRIPAN TABLETS 5MG

Approval Date
Jun 18, 2024
PPB

ATOZIN CAPSULES 250MG

Approval Date
May 13, 2024
PPB

ELLEZIN TABLETS 5MG

Approval Date
Apr 23, 2024
PPB

SAPRAX TABLETS 10MG

Approval Date
Feb 29, 2024
PPB

MONTOL TABLETS 10MG

Approval Date
Feb 29, 2024
PPB

SAPRAX TABLETS 5MG

Approval Date
Feb 29, 2024
PPB

IBFEN TABLETS 200MG

Approval Date
Nov 29, 2023
PPB
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.